Nombre de la Acción | Símbolo de la Acción | Bolsa de Valores | Tipo de Valor |
---|---|---|---|
NeuroSense Therapeutics Ltd | NRSNW | NASDAQ | Warrant Capital Accionario |
Precio de Apertura | Precio Mínimo | Precio Máximo | Precio de cierre | Precio Anterior |
---|---|---|---|---|
0.21 | 0.21 | 0.21 | 0.21 | 0.21 |
Noticias Recientes
Fecha | Hora | Fuente | Noticia |
---|---|---|---|
17/6/2024 | 16:25 | EDGAR2 | Form 424B3 - Prospectus [Rule 424(b)(3)] |
17/6/2024 | 16:24 | EDGAR2 | Form 424B3 - Prospectus [Rule 424(b)(3)] |
17/6/2024 | 16:22 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
28/5/2024 | 06:14 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
23/5/2024 | 15:00 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
22/5/2024 | 23:15 | EDGAR2 | Form EFFECT - Notice of Effectiveness |
22/5/2024 | 16:00 | EDGAR2 | Form 424B3 - Prospectus [Rule 424(b)(3)] |
20/5/2024 | 15:16 | EDGAR2 | Form F-1/A - Registration statement for certain foreign.. |
20/5/2024 | 08:02 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
14/5/2024 | 08:02 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
10/5/2024 | 15:15 | EDGAR2 | Form F-1 - Registration statement for certain foreign.. |
07/5/2024 | 09:21 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |